SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Theravance - THRX
An SI Board Since October 2004
Posts SubjectMarks Bans Symbol
74 12 0 THRX
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
74Theravance Announces Receipt of Additional FDA Communication Regarding Telavancitnsaf-1/28/2010
73UPDATE 1-FDA denies approval for Theravance's pneumonia drug Fri Nov 27, 200tnsaf-11/30/2009
72Theravance Announces New Employment Inducement Awards <i>Must be someone tnsaf-8/4/2009
71Three asthma phase IIb studies of the inhaled corticosteroid (ICS) GW685698 (idos-2/4/2009
70They have significantly lowered the tested doses in order to find an optimum safidos-12/22/2008
69If they can prove the safety advantage angle, this could be a huge product.rkrw-12/22/2008
68LABA '444 phase IIb results now in COPD. The two studies had similar design:idos-12/22/2008
67Next week, the FDA Pulmonary-Allergy Drugs Advisory Committees will discuss the idos-12/3/2008
66<b>GSK and Theravance Announce Positive Phase 2b Results for LABA, '44idos-12/2/2008
65Theravance Announces Posting of Briefing Documents for FDA Anti-Infective Drugs tnsaf-11/17/2008
64Theravance 1Q loss narrows, plans 40 percent job cut Monday April 21, 5:13 pm ETtnsaf-4/21/2008
63Theravance Announces Pricing of Convertible Subordinated Notes Offering Thursdaytnsaf-1/17/2008
62Theravance to Offer $150M Worth of Notes Tuesday January 15, 5:21 pm ET Theravantnsaf-1/15/2008
61FDA Sets Meeting for Theravance Drug Thursday January 10, 11:35 am ET FDA Experttnsaf-1/10/2008
60Theravance Says FDA to Review Telavancin Thursday December 27, 5:22 pm ET Theravtnsaf-12/27/2007
59Theravance Announces Positive Topline Results In Phase 3 Telavancin Hospital-Acqtnsaf-12/5/2007
58Theravance Announces Initiation of Phase 2 Clinical Program with its MABA Compoutnsaf-10/31/2007
57Thanks rkrw. I'd just listened to the CC on the approvable letter this mornkenhott-10/26/2007
56Tough question. Usually you can best judge integrity in hindsight! :-) I thinkrkrw-10/26/2007
55Hey rkrw. I know you follow these guys. Do you have an opinion about the integkenhott-10/26/2007
54Theravance Reports Third Quarter 2007 Financial Results Thursday October 25, 4:1tnsaf-10/25/2007
53FDA Needs More on Theravance Staph Drug Monday October 22, 7:46 am ET FDA Says Ntnsaf-10/22/2007
52>>Theravance Retains Full Ownership of Gastrointestinal Motility Dysfunctituck-9/7/2007
51>>Theravance Announces That GlaxoSmithKline Will Not Exercise Call Right Utuck-6/30/2007
50Merrill: Price Objective Changes Theravance Inc (THRX, US$31.32, C-1-9) Reiteratom pope-6/26/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News